REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy
- 1 December 2014
- journal article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 307 (11) , E983-E993
Abstract
REDD1 (regulated in development and DNA damage response 1) has been proposed to inhibit the mechanistic target of rapamycin complex 1 (mTORC1) during in vitro hypoxia. REDD1 expression is low under basal conditions but is highly increased in response to several catabolic stresses, like hypoxia and glucocorticoids. However, REDD1 function seems to be tissue and stress dependent, and its role in skeletal muscle in vivo has been poorly characterized. Here, we investigated the effect of REDD1 deletion on skeletal muscle mass, protein synthesis, proteolysis, and mTORC1 signaling pathway under basal conditions and after glucocorticoid administration. Whereas skeletal muscle mass and typology were unchanged between wild-type (WT) and REDD1-null mice, oral gavage with dexamethasone (DEX) for 7 days reduced tibialis anterior and gastrocnemius muscle weights as well as tibialis anterior fiber size only in WT. Similarly, REDD1 deletion prevented the inhibition of protein synthesis and mTORC1 activity (assessed by S6, 4E-BP1, and ULK1 phosphorylation) observed in gastrocnemius muscle of WT mice following single DEX administration for 5 h. However, our results suggest that REDD1-mediated inhibition of mTORC1 in skeletal muscle is not related to the modulation of the binding between TSC2 and 14-3-3. In contrast, our data highlight a new mechanism involved in mTORC1 inhibition linking REDD1, Akt, and PRAS40. Altogether, these results demonstrated in vivo that REDD1 is required for glucocorticoid-induced inhibition of protein synthesis via mTORC1 downregulation. Inhibition of REDD1 may thus be a strategy to limit muscle loss in glucocorticoid-mediated atrophy.Keywords
This publication has 49 references indexed in Scilit:
- Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoidsThe Journal of Physiology, 2011
- REDD1 (regulated in development and DNA damage response 1) expression in skeletal muscle as a surrogate biomarker of the efficiency of glucocorticoid receptor blockadeBiochemical and Biophysical Research Communications, 2011
- Glucocorticoid Elevation of Dexamethasone-induced Gene 2 (Dig2/RTP801/REDD1) Protein Mediates Autophagy in LymphocytesJournal of Biological Chemistry, 2011
- REDD1 Is a Major Target of Testosterone Action in Preventing Dexamethasone-Induced Muscle LossEndocrinology, 2009
- ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for AutophagyJournal of Biological Chemistry, 2009
- ULK-Atg13-FIP200 Complexes Mediate mTOR Signaling to the Autophagy MachineryMolecular Biology of the Cell, 2009
- ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expressionBiochemical and Biophysical Research Communications, 2009
- The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 geneAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttlingGenes & Development, 2008
- Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioningJournal of Cell Biology, 2006